Table 3: Effects of
formoterol and AR42 treatments on grip force in tumor-bearing rats.
Parameters |
|
|
Experimental groups |
|||||
|
C |
T |
T+F |
T+A |
T+F+A |
|||
Grip force day 0 |
340 ± 11 |
343 ± 12 |
342 ± 11 |
286 ± 18 * |
322 ± 27 |
|||
Grip force day 7 |
426 ± 20 |
357 ± 14 ## |
449 ± 11 *** |
257 ± 12 ** |
377 ± 13 |
|||
D grip force |
86 ± 19 |
15 ± 21 # |
107 ± 11 *** |
-29 ± 23 |
55 ± 24 |
|||
Results
are mean ± SEM for the number of animals: C (12), T (13), T+F (13), T+A (4),
T+F+A (7). D grip force was
calculated as [(grip force day 7- grip force day 0)/ IBW] * 100. Values that are significantly
different by the Student’s t-test from the control group (C) are indicated by #
p <0.05, ## p < 0.01, ### p < 0.001, and from the tumor non-treated
animal group (T) are indicated by * p <0.05, ** p <0.01, *** p < 0.001.
C: rats without tumor; T: Tumor-bearing rats; T+F:
Treated with Formoterol; T+A: Treated with AR42; T+F+A: Treated with both
Formoterol and AR42.